references
A WORD OF THANKS
DNDi would like to thank all of the donors worldwide for their loyal commitment and collaboration since 2003. To date, DNDi has delivered six new treatments and aims to bring 16-18 treatments in total to patients suffering from neglected diseases by 2023. DNDi is grateful for the support received from the following donors who contributed toward the advancement of its mission and goals. Listed are supporters who have given a contribution of USD or EUR 10,000 cumulatively.
Public Institutional Support • Banco Nacional de Desenvolvimento Econômico e Social (BNDES), Brazil • Department for International Development (DFID), UK • Dutch Ministry of Foreign Affairs (DGIS), The Netherlands • European Union – Framework Programmes 5, 6 and 7, International • European and Developing Countries Clinical Trials Partnerships (EDCTP) with co-funding from Member States, International • Federal Ministry of Education and Research (BMBF) through KfW, Germany • French Development Agency (AFD), France • German International Cooperation (GIZ) on behalf of the Government of the Federal Republic of Germany, Germany • Global Health Innovative Technology Fund (GHIT Fund), Japan • The Global Fund to Fight AIDS, Tuberculosis and Malaria (AMFm), International • Minister of Foreign Affairs and International Development (MAEDI), France • Ministry of Health, Brazil • National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID), USA • Norwegian Agency for Development Cooperation (Norad), Norway • Republic and Canton of Geneva, Switzerland • Region of Tuscany, Italy • Ruta-N, City of Medellin, Colombia • Science and Technology Innovation Agency (FINEP), Brazil • Spanish Agency for International Cooperation (AECID), Spain Development Private Support • Anonymous individuals and organizations • Associação Bem-Te-Vi Diversidade, Brazil • Bennett Shapiro and Fredericka Foster, USA • Bill & Melinda Gates Foundation, USA • BBVA Foundation (through the ‘Frontiers of Knowledge Award in Development Cooperation’), Spain • Brian Mercer Charitable Trust, UK • Carlos Slim Foundation through the Carlos Slim Health Award, Mexico • David and Lisa U’Prichard, USA • Family of Richard Rockefeller, USA • Fondation André & Cyprien, Switzerland • Fondation ARPE, Switzerland • Fondation de bienfaisance du groupe Pictet, Switzerland • Fondation Pro Victimis, Switzerland • George H. Stout, USA • Goldman, Sachs & Co., USA • Guy’s, King’s and St Thomas’, Giving Week, UK • Harlan and Sally Weisman, USA • Jeffrey Nelson, USA • Leopold Bachmann Foundation, Switzerland • Marsha Fanucci, USA • Médecins Sans Frontières International and the MSF sections of Italy, Norway, and Brazil • Medicor Foundation, Liechtenstein • Rockefeller Brothers Fund, USA • The Rockefeller Foundation (through the ‘Next Century Innovators Award’), USA • The Peter and Carmen Lucia Buck Foundation, USA • The Stainman Family Foundation, USA • The Wellcome Trust, UK • Steve Rabin and Jonathan Winslow, USA • Sandoz Family Foundation, Switzerland • Sasakawa Peace Foundation, Japan • Starr International Foundation, Switzerland • UBS Optimus Foundation, Switzerland • United States Agency for International Development (USAID), via the 4th Sector Health Project implemented by Abt Associates, Inc., USA
• Swiss Agency for Development and Cooperation (SDC), Switzerland • World Health Organization - Special Programme for Research and Training in Tropical Diseases (WHO-TDR) • UNITAID, International • United States Agency for International Development (USAID), USA
90 › DNDi Annual Report 2015
